International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Clinical trial NCT06839703 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06839703
- Sponsor
- Prof. Dr. Dirk Reinhardt
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.